Navigation Links
Emerging staph strains found to be increasingly deadly and deceptive

A study of how the immune system reacts to strains of antibiotic-resistant Staphylococcus aureus bacteria--emerging strains that sicken otherwise healthy people, or so-called "community-acquired" infections--has shown for the first time that these strains are more deadly and better at evading human immune defenses than more common S. aureus strains that originate in hospitals and other health-care settings.

In a paper released today online in The Journal of Immunology, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, describe how community-acquired S. aureus strains that survive treatment with the methicillin family of antibiotics can evade immune defenses. Infections from community-acquired methicillin-resistant S. aureus, or MRSA, are difficult to treat and are increasing nationally at an alarming rate, say experts.

Scientists at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, MT, and colleagues examined the ability of MRSA strains to cause disease in mice and avoid destruction by human white blood cells called neutrophils. Neutrophils, which typically ingest and then kill harmful bacteria, make up about 60 percent of all white blood cells and are the first line of defense against bacteria. Scientists know that community-acquired strains differ from hospital strains, but they don't know why the community strains cause more serious infection in otherwise healthy people.

The work also identified specific S. aureus genes that potentially control the bacterium's escape from neutrophils. Among thousands of S. aureus genes analyzed in the five different strains used in the study, the scientists identified a large group of genes whose role in helping spread infection is unknown. RML's Frank DeLeo, Ph.D., the investigator who directed the study, and colleagues plan to determine if some of the unknown genes help promote disease. If they can learn which genes control t he ability of S. aureus to evade and destroy neutrophils, their work could lead to new medical treatments.

"Each day physicians around the world are stymied by the inability to effectively treat patients suffering from severe S. aureus infections," says NIAID Director Anthony S. Fauci, M.D. "There is a critical need to develop new treatments against late-stage disease caused by antibiotic-resistant strains, and this promising work offers several new approaches."

According to the Centers for Disease Control and Prevention, "recent reports of 'community-acquired' MRSA infections raise concern ?If MRSA becomes the most common form of Staphylococcus aureus in a community, it will make treatment of common infections much more difficult." The April 7, 2005, issue of The New England Journal of Medicine refers in an editorial to "?an epidemic of MRSA in the community."

S. aureus strains acquired in health-care settings can be challenging to resolve because of antibiotic resistance, which limits the choices for treatment. But the situation can become more serious with the newer community-acquired strains, says Dr. DeLeo. "We do not know why cases of community-acquired MRSA infections are increasing, let alone how they flourish," he says. But scientists do know the community strains can cause more severe forms of disease.

Mild S. aureus infections such as impetigo, which typically forms small blisters on the faces of children, or cellulitis, an inflammation of skin or muscle tissue, can easily be treated and usually resolve in a matter of days. But S. aureus disease also can be much more severe and difficult to treat, affecting vital organs and leading to toxins poisoning the blood and infection overwhelming the heart. One of the most severe types of disease is necrotizing pneumonia, where bacteria destroy lung tissue.

"The reason that some mild infections become severe or fatal is not well understood, but virulence is often associated with certain strains," says Jovanka Voyich, Ph.D., of RML, the study's lead author. To cause human disease, bacterial pathogens must avoid being killed by neutrophils. "These results," says Dr. Voyich, "suggest that community-acquired MRSA causes disease in healthy people in part because it has enhanced ability to circumvent killing by neutrophils."


'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Related biology news :

1. Ticks, flukes, and genomics: Emerging pathogens revealed
2. Substance protects resilient staph bacteria
3. Study indicates dramatic rise in antibiotic-resistant community-acquired staph infections
4. Less virulent strains of avian influenza can infect humans
5. Study outlines genetic differences between potential pandemic influenza strains
6. Human behavior changes the number of strains of infectious diseases
7. Experimental vaccine protects lab animals against several strains of H5N1
8. Complexity constrains evolution of human brain genes
9. New test for most virulent HPV strains under study
10. New component of the brakes on nerve regeneration found
11. Strongest proof yet found for prion hypothesis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... States multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® ... identifying clinically significant acute bacterial and viral respiratory tract infections by testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: